Inhaled corticosteroids and hospitalisation due to exacerbation of COPD

European Respiratory Journal

Volumn 22, Issue 2, 2003, Pages 286-289

  Bourbeau, J ^a   Ernst, Pierre ^b   Cockcoft, D ^c   Suissa, S ^b  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

^c ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

Chronic obstructive pulmonary disease; Inhaled corticosteroids; Morbidity

Indexed keywords

ANTIBIOTIC AGENT; BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; IPRATROPIUM BROMIDE; KETOTIFEN; NEDOCROMIL; XANTHINE;

AGE DISTRIBUTION; AGED; ARTICLE; ARTIFICIAL VENTILATION; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG MEGADOSE; DRUG USE; FACTUAL DATABASE; FEMALE; HOSPITALIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; TIME;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SASKATCHEWAN; SEVERITY OF ILLNESS INDEX;

EID: 0041525657     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00113802     Document Type: Article

References (16)

1. Jackevicius C, Joyce DP, Kesten S, Chapman KR. Pre-hospitalization inhaled corticosteroid use in patients with COPD or asthma. Chest 1997; 111: 296-302.
2. van Andel AE, Reisner C, Menjoge SS, Witek TJ. Analysis of inhaled corticosteroid and oral theophylline use among patients witb stable COPD from 1987 to 1995. Chest 1999; 115: 703-707.
3. Keatings VM, Jatakanon A, Worsdell YM, Barnes PJ. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997; 155: 542-548.
4. Culpitt SV, Maziak W, Loukidis S, Nightingale JA, Matthews JL, Barnes PJ. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1635-1639.
5. Vestbo J, Sorensen T, Lange P, Brix A, Torre P, Viskum K. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 1999; 353: 1819-1823.
6. The Lung Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 2000; 343: 1902-1909.
7. Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000; 320: 1297-1303.
8. Pauwels RA, Lofdahl CG, Laitinen LA, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med 1999; 340: 1948-1953.
9. Alsaeedi A, Sin DD, McAlister FA. The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med 2002; 113: 59-65.
10. Sin DD, Tu JV. Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 580-584.
11. Downey W, Beck P, McNutt M, Stang M, Osei W, Nichol J. Health databases in Saskatchewan. In: Strom BL, ed, Pharmacoepidemiology. 3rd Edn. New York, John Wiley & Sons, Ltd, 2000; pp. 325-346.
12. Lubin JH, Gail MH. Biased selection of controls for case-control analyses for cohort studies. Biometrics 1984; 40: 63-75.
13. Suissa S. Novel approaches to pharmacoepidemiology: study design and statistical analysis. In: Strom BL, ed. Pharmacoepidemiology. 3rd Edn. New York, John Wiley & Sons, Ltd, 2000; pp. 785-805.
14. Rawson NS, Malcolm E. Validity of the recording of ischaemic heart disease and chronic obstructive pulmonary disease in the Saskatchewan health care datafiles. Stats Med 1995; 14: 2627-2643.
15. Blais L, Ernst P, Boivin JF, Suissa S. Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med 1998; 158: 126-132.
16. Blais L, Suissa S, Boivin JF, Ernst P. First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma. Thorax 1998; 53: 1025-1029.